×
About 21,850 results

ALLMedicine™ Contraception Center

Research & Reviews  6,194 results

How do thiol disulfide balance and copper-ceruloplasmin levels change in women using co...
https://doi.org/10.1080/09513590.2022.2089650
Gynecological Endocrinology : the Official Journal of The... Korkmaz H, Deveci CD et. al.

Jun 28th, 2022 - We aimed to examine the change in plasma copper (Cu) level and copper transport proteins level before inserting Cu-IUD and after one menstrual cycle and to show the effect of this change on the thiol disulfide balance in women using copper-contain...

Qualitative analysis of user reviews from Nurx and Planned Parenthood Direct: what user...
https://doi.org/10.1071/SH22005
Sexual Health; Nitkowski J

Jun 27th, 2022 - Telecontraception is a novel method that aims to address existing barriers associated with obtaining contraception in the United States, yet research examining user experiences with these apps is lacking. Qualitative data analysis was used to cond...

Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPR...
https://doi.org/10.1016/j.msard.2022.103963
Multiple Sclerosis and Related Disorders; Bove R, Hellwig K et. al.

Jun 27th, 2022 - Most disease-modifying therapies (DMTs) approved for the treatment of multiple sclerosis (MS) are not recommended during pregnancy, and discouraged while breastfeeding. However, discontinuation of some DMTs before pregnancy can leave women vulnera...

Now Is the Time to Safeguard Access to Emergency Contraception Before Abortion Restrict...
https://doi.org/10.1016/j.contraception.2022.06.008
Contraception Cleland K, Kumar B et. al.

Jun 27th, 2022 - Abortion and contraception are essential components of reproductive healthcare. As 26 states are likely to severely restrict access to abortion following the Supreme Court decision in Dobbs v. Jackson Women's Health Organization, access to emergen...

Contraception among HIV-positive women in Latvia- knowledge, experience and factors inf...
https://doi.org/10.1080/13625187.2022.2088730
The European Journal of Contraception & Reproductive Heal... Bule V, Pitkevica I et. al.

Jun 25th, 2022 - Latvia has one of the highest numbers of new HIV cases in the EU. The latest SRH national survey confirmed low effective contraceptive prevalence in the general population, no data were available about women living with HIV (WLHIV). The study aime...

see more →

Guidelines  43 results

Guideline No. 425a: Cannabis Use Throughout Women's Lifespans - Part 1: Fertility, Cont...
https://doi.org/10.1016/j.jogc.2022.01.012
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Robert M, Graves LE et. al.

Apr 12th, 2022 - To provide health care providers with the best evidence on cannabis use with respect to women's health. Areas of focus include general patterns of cannabis use as well as safety of use; care for women who use cannabis; stigma; screening, brief int...

Directive clinique no 425a : Le cannabis aux différentes périodes de la vie des femmes ...
https://doi.org/10.1016/j.jogc.2022.02.013
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Robert M, Graves LE et. al.

Apr 12th, 2022 - Fournir aux fournisseurs de soins de santé les meilleures données probantes sur l'utilisation de cannabis et la santé des femmes. Les domaines d'intérêt sont : les profils généraux d'utilisation du cannabis ainsi que la sécurité de la consommation...

Committee Opinion No. 419: Coercion Free Contraceptive Care.
https://doi.org/10.1016/j.jogc.2021.07.001
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Black A, Bow M et. al.

Jul 10th, 2021 - To provide guidance on culturally competent contraception counselling that is free of coercion and promotes shared decision-making and patient autonomy. Individuals of reproductive age who seek contraception or counselling for family planning. Con...

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200366
Maturitas Ramírez I, De la Viuda E et. al.

Jun 6th, 2020 - COVID-19 is associated with a systemic inflammatory response with activation of coagulation in symptomatic patients. The possibility of coagulopathies in peri- and postmenopausal women taking estrogen therapies makes it necessary to consider antit...

Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recomm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147901
MMWR. Morbidity and Mortality Weekly Report; Tepper NK, Curtis KM et. al.

Apr 10th, 2020 - "U.S. Medical Eligibility Criteria for Contraceptive Use" (U.S. MEC) 2016 provides evidence-based guidance for the safe use of contraceptive methods among U.S. women with certain characteristics or medical conditions (1). The U.S. MEC is adapted f...

see more →

Drugs  341 results see all →

Clinicaltrials.gov  763 results

Electronic Sexual Reproductive Health CDS Tool at the Children's Hospital of Philadelphia
https://clinicaltrials.gov/ct2/show/NCT04974086

Jun 23rd, 2022 - The SRH CDS tool will be embedded within the electronic health record (EHR) and will be evaluated to include feasibility (through medical record review for EHR utilization data), pediatric clinician acceptability and usability of the intervention ...

Care After Pregnancy Study (CAPS): Engaging Women in Postpartum Care
https://clinicaltrials.gov/ct2/show/NCT04257552

Jun 22nd, 2022 - There are profound economic inequalities in a wide range of important maternal and child health outcomes ranging from neonatal death to maternal morbidity and mortality. The overarching scientific premise for our proposal is that these inequalitie...

Evaluating the Impact of CHOICE-AYA on Contraceptive Use, Continuation and Satisfaction
https://clinicaltrials.gov/ct2/show/NCT05022134

Jun 22nd, 2022 - This study will adapt an evidence-based contraceptive counseling intervention (CHOICE) using input from the formative groups of AYA experiencing homelessness and study the impact of the adapted counseling (CHOICE-AYA) on contraceptive use, continu...

A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)
https://clinicaltrials.gov/ct2/show/NCT04626596

Jun 22nd, 2022 - The primary purpose of this study is to assess the efficacy and safety of the etonogestrel (ENG) contraceptive implant during participants' fourth and fifth years of use when used as the only method of contraception. The ENG implant is currently a...

MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study: MIDAS Study
https://clinicaltrials.gov/ct2/show/NCT01961375

Jun 21st, 2022 - The study is designed as non interventional to observe the continuation rate and the patient satisfaction in women who have a LNG-IUS (Levonorgestrel releasing Intrauterine system) inserted for contraception over the period of 12 months under real...

see more →

News  1,396 results

SC Medical Ethics Law Prompts Concerns Re: LGBTQ Healthcare
https://www.medscape.com/viewarticle/976037

Jun 22nd, 2022 - A new South Carolina law that allows physicians, medical students and nurses to refrain from doing procedures that violate their conscience has prompted concern that the measure will restrict healthcare options for the state's LGBTQ population. Si...

MS and family planning: Bring it up at every office visit
https://www.mdedge.com/neurology/article/255359/multiple-sclerosis/ms-and-family-planning-bring-it-every-office-visit
Randy Dotinga

Jun 10th, 2022 - NATIONAL HARBOR, MD – Just 2 days before she spoke in a presentation at the annual meeting of the Consortium of Multiple Sclerosis Centers, University of Colorado neurologist Anna Shah, MD, asked a 26-year-old patient with MS about whether she pla.

Double morning-after pill dose for women with obesity not effective
https://www.mdedge.com/obgyn/article/255336/contraception/double-morning-after-pill-dose-women-obesity-not-effective
Marcia Frellick

Jun 9th, 2022 - Emergency contraception is more likely to fail in women with obesity, but simply doubling the dose of levonorgestrel (LNG)-based contraception does not appear to be effective according to the results of a randomized, controlled trial. Alison B.

Tin in Permanent Contraception Implants Causes Toxicity
https://www.medscape.com/viewarticle/974841

May 31st, 2022 - LYON, France — Essure implants arrived on the market in 2002 as permanent contraception for women older than age 45 years with children. They were recalled in 2017. Presented as an alternative to laparoscopic tubal ligation, this medical device re...

Oklahoma Gov. Signs Bill That Bans Nearly All Abortions
https://www.medscape.com/viewarticle/974690

May 26th, 2022 - Oklahoma Gov. Kevin Stitt signed a bill into law on Wednesday that bans almost all abortions in the state, starting at fertilization. The new law is the most restrictive abortion ban in the U.S., making exceptions only when an abortion is necessar...

see more →

Patient Education  3 results see all →